Popular
BlogNEW
CompaniesNEW
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Investor Presentaiton slide image

Investor Presentaiton

BND-22 development plan: potential initial efficacy signals by mid-2023 2020 2021 2022 2023 2024 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 IND BND-22 Monotherapy BND-22 Monotherapy BND-22 + Cetuximab BND-22 + anti-PD-1 Dose Escalation 8 sites; US and Israel Dose Expansion 15-20 sites; US, EU and Israel IND, Investigational New Drug; FPI, First Patient In BND-22 + Cetuximab BND-22 + anti-PD-1 BIOND BIOLOGICS Biond Biologics Corporate Presentation | May 2021 | Non-confidential 12
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube